{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:01:11Z","timestamp":1793628071648,"version":"4.5.1"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00415-025-13346-z","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:01:51Z","timestamp":1765972911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The diagnostic value of plasma A\u03b242 and A\u03b240 in Alzheimer\u2019s disease: current status, challenges, and impacting variables"],"prefix":"10.1007","volume":"273","author":[{"given":"Xiuzhi","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenli","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixingmao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuchu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"13346_CR1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","volume":"67","author":"A Kumar","year":"2015","unstructured":"Kumar A, Singh A, Ekavali (2015) A review on Alzheimer\u2019s disease pathophysiology and its management: an update. Pharmacol Rep 67:195\u2013203","journal-title":"Pharmacol Rep"},{"key":"13346_CR2","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","volume":"19","author":"MA Better","year":"2023","unstructured":"Better MA (2023) Alzheimer\u2019s disease facts and figures. Alzheimers Dement 19:1598\u20131695","journal-title":"Alzheimers Dement"},{"key":"13346_CR3","volume":"14","author":"C Abdelnour","year":"2022","unstructured":"Abdelnour C, Agosta F, Bozzali M, Foug\u00e8re B, Iwata A, Nilforooshan R, Takada LT, Vi\u00f1uela F, Traber M (2022) Perspectives and challenges in patient stratification in Alzheimer\u2019s disease. Alzheimers Res Ther 14:112","journal-title":"Alzheimers Res Ther"},{"key":"13346_CR4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13024-021-00424-9","volume":"16","author":"J Cummings","year":"2021","unstructured":"Cummings J (2021) New approaches to symptomatic treatments for Alzheimer\u2019s disease. Mol Neurodegener 16:2","journal-title":"Mol Neurodegener"},{"key":"13346_CR5","doi-asserted-by":"publisher","unstructured":"2024 Alzheimer's disease facts and figures. Alzheimers Dement 20(5):3708\u20133821. https:\/\/doi.org\/10.1002\/alz.13809. Epub 2024 Apr 30. PMID: 38689398; PMCID: PMC11095490.","DOI":"10.1002\/alz.13809"},{"key":"13346_CR6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"Villemagne Victor L","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL, for the Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group (2013) Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol 12:357\u2013367","journal-title":"Lancet Neurol"},{"key":"13346_CR7","first-page":"45","volume":"2","author":"Robert H Pietrzak","year":"2017","unstructured":"Pietrzak RH, Laws SM, Lim YY, Bender SJ, Porter T, Doecke J, Ames D, Fowler C, Masters CL, Milicic L, Rainey-Smith S, Villemagne VL, Rowe CC, Martins RN, Maruff P, for the Australian Imaging, Biomarkers and Lifestyle Research Group (2017) Plasma cortisol, brain amyloid-\u03b2, and cognitive decline in preclinical Alzheimer\u2019s disease: a 6-year prospective cohort study. Biol Psychiatry Cogn Neurosci Neuroimaging 2:45\u201352","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"13346_CR8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1001\/jamapsychiatry.2014.2476","volume":"72","author":"Robert H Pietrzak","year":"2015","unstructured":"Pietrzak RH, Lim YY, Neumeister A, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Restrepo C, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P, for the Australian Imaging, Biomarkers, and Lifestyle Research Group (2015) Amyloid-\u03b2, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study. JAMA Psychiat 72:284\u2013291","journal-title":"JAMA Psychiat"},{"key":"13346_CR9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/acn3.51770","volume":"10","author":"T Nakamura","year":"2023","unstructured":"Nakamura T, Kawarabayashi T, Nakahata N, Itoh K, Ihara K, Nakaji S, Ikeda Y, Takatama M, Shoji M (2023) Annual stability of the plasma A\u00df40\/42 ratio and associated factors. Ann Clin Transl Neurol 10:879\u2013891","journal-title":"Ann Clin Transl Neurol"},{"key":"13346_CR10","doi-asserted-by":"crossref","first-page":"17082","DOI":"10.1016\/S0021-9258(18)41896-0","volume":"267","author":"H Mori","year":"1992","unstructured":"Mori H, Takio K, Ogawara M, Selkoe DJ (1992) Mass spectrometry of purified amyloid beta protein in Alzheimer\u2019s disease. J Biol Chem 267:17082\u201317086","journal-title":"J Biol Chem"},{"key":"13346_CR11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2174\/1567205016666190517121140","volume":"16","author":"Leonardo Guzman-Martinez","year":"2019","unstructured":"Guzman-Martinez L, Maccioni RB, Far\u00edas GA, Fuentes P, Navarrete LP (2019) Biomarkers for Alzheimer\u2019s disease. Curr Alzheimer Res 16:518\u2013528","journal-title":"Curr Alzheimer Res"},{"issue":"39","key":"13346_CR12","doi-asserted-by":"publisher","first-page":"e2404916","DOI":"10.1002\/advs.202404916","volume":"11","author":"N Meyer","year":"2024","unstructured":"Meyer N, Arroyo N, Roustan L, Janot J-M, Charles-Achille S, Torrent J, Picaud F, Balme S (2024) Secondary nucleation of A\u03b2 revealed by single-molecule and computational approaches. Adv Sci (Weinh) 11(39):e2404916. https:\/\/doi.org\/10.1002\/advs.202404916. Epub 2024 Aug 19. PMID: 39159070; PMCID: PMC11497034","journal-title":"Adv Sci (Weinh)"},{"key":"13346_CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13024-023-00654-z","volume":"18","author":"Arun Upadhyay","year":"2023","unstructured":"Upadhyay A, Chhangani D, Rao NR, Kofler J, Vassar R, Rincon-Limas DE, Savas JN (2023) Amyloid fibril proteomics of AD brains reveals modifiers of aggregation and toxicity. Mol Neurodegener 18:61","journal-title":"Mol Neurodegener"},{"key":"13346_CR14","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41591-024-02988-7","volume":"30","author":"Clifford R Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews SJ, Beach TG, Buracchio T, Dunn B, Graf A, Hansson O, Ho C, Jagust W, McDade E, Molinuevo JL, Okonkwo OC, Pani L, Rafii MS, Scheltens P, Siemers E, Snyder HM, Sperling R, Teunissen CE, Carrillo MC (2024) Revised criteria for the diagnosis and staging of Alzheimer\u2019s disease. Nat Med 30:2121\u20132124","journal-title":"Nat Med"},{"key":"13346_CR15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol Rev 81:741\u2013766","journal-title":"Physiol Rev"},{"key":"13346_CR16","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1021\/acschemneuro.2c00358","volume":"13","author":"SG Itoh","year":"2022","unstructured":"Itoh SG, Yagi-Utsumi M, Kato K, Okumura H (2022) Key residue for aggregation of amyloid-\u03b2 peptides. ACS Chem Neurosci 13:3139\u20133151","journal-title":"ACS Chem Neurosci"},{"key":"13346_CR17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/jnc.12202","volume":"126","author":"Lei Gu","year":"2013","unstructured":"Gu L, Guo Z (2013) Alzheimer\u2019s A\u03b242 and A\u03b240 peptides form interlaced amyloid fibrils. J Neurochem 126:305\u2013311","journal-title":"J Neurochem"},{"key":"13346_CR18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.semcdb.2020.04.002","volume":"105","author":"Satoru Funamoto","year":"2020","unstructured":"Funamoto S, Tagami S, Okochi M, Morishima-Kawashima M (2020) Successive cleavage of \u03b2-amyloid precursor protein by \u03b3-secretase. Semin Cell Dev Biol 105:64\u201374","journal-title":"Semin Cell Dev Biol"},{"key":"13346_CR19","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","volume":"93","author":"SE Schindler","year":"2019","unstructured":"Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Li Y, Gordon BA, Holtzman DM, Morris JC, Benzinger TLS, Xiong C, Fagan AM, Bateman RJ (2019) High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis. Neurology 93:e1647\u2013e1659","journal-title":"Neurology"},{"key":"13346_CR20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/jnnp-2021-327864","volume":"93","author":"L Cheng","year":"2022","unstructured":"Cheng L, Li W, Chen Y, Lin Y, Wang B, Guo Q, Miao Y (2022) Plasma Abeta as a biomarker for predicting Abeta-PET status in Alzheimer\u2019s disease: a systematic review with meta-analysis. J Neurol Neurosurg Psychiatry 93:513\u2013520","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13346_CR21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0304-3940(01)01754-2","volume":"304","author":"PD Mehta","year":"2001","unstructured":"Mehta PD, Pirttila T, Patrick BA, Barshatzky M, Mehta SP (2001) Amyloid beta protein 1\u201340 and 1\u201342 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease. Neurosci Lett 304:102\u2013106","journal-title":"Neurosci Lett"},{"key":"13346_CR22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, van der Flier WM, Mielke MM, Del Campo M (2022) Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol 21:66\u201377","journal-title":"Lancet Neurol"},{"key":"13346_CR23","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.25334","volume":"84","author":"IMW Verberk","year":"2018","unstructured":"Verberk IMW, Slot RE, Verfaillie SCJ, Heijst H, Prins ND, van Berckel BNM, Scheltens P, Teunissen CE, van der Flier WM (2018) Plasma amyloid as prescreener for the earliest Alzheimer pathological changes. Ann Neurol 84:648\u2013658","journal-title":"Ann Neurol"},{"key":"13346_CR24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jalz.2016.09.014","volume":"13","author":"SE O'Bryant","year":"2017","unstructured":"O'Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, Lewczuk P, Posner H, Hall J, Johnson L, Fong YL, Luthman J, Jeromin A, Batrla-Utermann R, Villarreal A, Britton G, Snyder PJ, Henriksen K, Grammas P, Gupta V, Martins R, Hampel H; Biofluid Based Biomarker Professional Interest Area (2017) Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimers Dement 13:45\u201358","journal-title":"Alzheimers Dement"},{"key":"13346_CR25","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1126\/science.adn5820","volume":"384","author":"Xuefei Guo","year":"2024","unstructured":"Guo X, Li H, Yan C, Lei J, Zhou R, Shi Y (2024) Molecular mechanism of substrate recognition and cleavage by human \u03b3-secretase. Science (New York, NY) 384:1091\u20131095","journal-title":"Science (New York, NY)"},{"key":"13346_CR26","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1242\/dev.108712","volume":"141","author":"M Nicolas","year":"2014","unstructured":"Nicolas M, Hassan BA (2014) Amyloid precursor protein and neural development. Development 141:2543\u20132548","journal-title":"Development"},{"key":"13346_CR27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/ijms21010209","volume":"21","author":"T Zhang","year":"2019","unstructured":"Zhang T, Chen D, Lee TH (2019) Phosphorylation signaling in APP processing in Alzheimer\u2019s disease. Int J Mol Sci 21:209","journal-title":"Int J Mol Sci"},{"key":"13346_CR28","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1073\/pnas.96.2.742","volume":"96","author":"JP Greenfield","year":"1999","unstructured":"Greenfield JP, Tsai J, Gouras GK, Hai B, Thinakaran G, Checler F, Sisodia SS, Greengard P, Xu H (1999) Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc Natl Acad Sci USA 96:742\u2013747","journal-title":"Proc Natl Acad Sci USA"},{"key":"13346_CR29","first-page":"696","volume":"48","author":"I Popov","year":"2015","unstructured":"Popov I, Inde\u012dkina M, Pekov S, Starodybtseva N, Kononikhin A, Nikolaeva M, Kukaev E, Kostiukevich Iu I, Kozin S, Makarov A, Nikolaev E (2015) Estimation of phosphorilation level of amyloid beta, extracted from human blood plasma. Ultra high resolution mass spectrometry. Mol Biol (Mosk) 48:696\u2013704","journal-title":"Mol Biol (Mosk)"},{"key":"13346_CR30","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.3390\/ijms21124477","volume":"21","author":"YR Huang","year":"2020","unstructured":"Huang YR, Liu RT (2020) The toxicity and polymorphism of \u03b2-Amyloid oligomers. Int J Mol Sci 21:4477","journal-title":"Int J Mol Sci"},{"key":"13346_CR31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"Jenna M Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV, Frangione B, Blennow K, M\u00e9nard J, Zetterberg H, Wisniewski T, de Leon MJ (2015) Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol 11:457\u2013470","journal-title":"Nat Rev Neurol"},{"issue":"147","key":"13346_CR32","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, Nagelhus EA (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2.[J]. Sci Transl Med 4(147):147ra111. https:\/\/doi.org\/10.1126\/scitranslmed.3003748.","journal-title":"Sci Transl Med"},{"key":"13346_CR33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff\u2013Conway","year":"2015","unstructured":"Tarasoff\u2013Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV, Frangione B, Blennow K, M\u00e9nard J, Zetterberg H, Wisniewski T, de Leon MJ (2015) Clearance systems in the brain\u2014implications for Alzheimer disease. Nat Rev Neurol 11:457\u201370","journal-title":"Nat Rev Neurol"},{"key":"13346_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0457-0","volume":"117","author":"RO Weller","year":"2009","unstructured":"Weller RO, Djuanda E, Yow H-Y, Carare RO (2009) Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol 117:1-14","journal-title":"Acta Neuropathol"},{"key":"13346_CR35","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S1474-4422(18)30318-1","volume":"17","author":"MK Rasmussen","year":"2018","unstructured":"Rasmussen MK, Mestre H, Nedergaard M (2018) The glymphatic pathway in neurological disorders. Lancet Neurol 17:1016\u20131024","journal-title":"Lancet Neurol"},{"key":"13346_CR36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ana.24270","volume":"76","author":"KF Roberts","year":"2014","unstructured":"Roberts KF, Elbert DL, Kasten TP, Patterson BW, Sigurdson WC, Connors RE, Ovod V, Munsell LY, Mawuenyega KG, Miller-Thomas MM, Moran CJ, Cross DT 3rd, Derdeyn CP, Bateman RJ (2014) Amyloid-\u03b2 efflux from the central nervous system into the plasma. Ann Neurol 76:837\u2013844","journal-title":"Ann Neurol"},{"key":"13346_CR37","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1038\/mp.2017.204","volume":"23","author":"XL Bu","year":"2018","unstructured":"Bu XL, Xiang Y, Jin WS, Wang J, Shen LL, Huang ZL, Zhang K, Liu YH, Zeng F, Liu JH, Sun HL, Zhuang ZQ, Chen SH, Yao XQ, Giunta B, Shan YC, Tan J, Chen XW, Dong ZF, Zhou HD, Zhou XF, Song W, Wang YJ (2018) Blood-derived amyloid-\u03b2 protein induces Alzheimer\u2019s disease pathologies. Mol Psychiatry 23:1948\u20131956","journal-title":"Mol Psychiatry"},{"key":"13346_CR38","volume":"19","author":"Virginie Lam","year":"2021","unstructured":"Lam V, Takechi R, Hackett MJ, Francis R, Bynevelt M, Celliers LM, Nesbit M, Mamsa S, Arfuso F, Das S, Koentgen F, Hagan M, Codd L, Richardson K, O\u2019Mara B, Scharli RK, Morandeau L, Gauntlett J, Leatherday C, Boucek J, Mamo JCL (2021) Synthesis of human amyloid restricted to liver results in an Alzheimer disease-like neurodegenerative phenotype. PLoS Biol 19:e3001358","journal-title":"PLoS Biol"},{"key":"13346_CR39","doi-asserted-by":"crossref","first-page":"2167172","DOI":"10.1080\/19490976.2023.2167172","volume":"15","author":"Jinghua Jin","year":"2023","unstructured":"Jin J, Xu Z, Zhang L, Zhang C, Zhao X, Mao Y, Zhang H, Liang X, Wu J, Yang Y, Zhang J (2023) Gut-derived \u03b2-amyloid: likely a centerpiece of the gut-brain axis contributing to Alzheimer\u2019s pathogenesis. Gut Microbes 15:2167172","journal-title":"Gut Microbes"},{"key":"13346_CR40","doi-asserted-by":"crossref","first-page":"571083","DOI":"10.3389\/fimmu.2020.571083","volume":"11","author":"M Inyushin","year":"2020","unstructured":"Inyushin M, Zayas-Santiago A, Rojas L, Kucheryavykh L (2020) On the role of platelet-generated amyloid beta peptides in certain amyloidosis health complications. Front Immunol 11:571083","journal-title":"Front Immunol"},{"issue":"1","key":"13346_CR41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","volume":"5","author":"AE Roher","year":"2009","unstructured":"Roher AE, Esh CL, Kokjohn TA, Casta\u00f1o EM, Van Vickle GD, Kalback WM, Patton RL, Luehrs DC, Daugs ID, Kuo Y-M, Emmerling MR, Soares H, Quinn JF, Kaye J, Connor DJ, Silverberg NB, Adler CH, Seward JD, Beach TG, Sabbagh MN (2009) Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement 5(1):18\u201329","journal-title":"Alzheimers Dement"},{"key":"13346_CR42","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jalz.2017.06.2266","volume":"13","author":"V Ovod","year":"2017","unstructured":"Ovod V, Ramsey KN, Mawuenyega KG, Bollinger JG, Hicks T, Schneider T, Sullivan M, Paumier K, Holtzman DM, Morris JC, Benzinger T, Fagan AM, Patterson BW, Bateman RJ (2017) Amyloid \u03b2 concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimers Dement 13:841\u2013849","journal-title":"Alzheimers Dement"},{"key":"13346_CR43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","volume":"140","author":"SA Kent","year":"2020","unstructured":"Kent SA, Spires-Jones TL, Durrant CS (2020) The physiological roles of tau and A\u03b2: implications for Alzheimer\u2019s disease pathology and therapeutics. Acta Neuropathol 140:417\u2013447","journal-title":"Acta Neuropathol"},{"key":"13346_CR44","doi-asserted-by":"crossref","first-page":"102578","DOI":"10.1016\/j.arr.2024.102578","volume":"102","author":"Anna Maggiore","year":"2024","unstructured":"Maggiore A, Latina V, D\u2019Erme M, Amadoro G, Coccurello R (2024) Non-canonical pathways associated to Amyloid beta and tau protein dyshomeostasis in Alzheimer\u2019s disease: a narrative review. Ageing Res Rev 102:102578","journal-title":"Ageing Res Rev"},{"key":"13346_CR45","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"Hadas Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, Itzkovitz S, Colonna M, Schwartz M, Amit I (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169:1276\u20131290.e1217","journal-title":"Cell"},{"key":"13346_CR46","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"Michael T Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14:388\u2013405","journal-title":"Lancet Neurol"},{"key":"13346_CR47","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1515\/revneuro-2022-0087","volume":"34","author":"Gunel Ayyubova","year":"2023","unstructured":"Ayyubova G (2023) Dysfunctional microglia and tau pathology in Alzheimer\u2019s disease. Rev Neurosci 34:443\u2013458","journal-title":"Rev Neurosci"},{"key":"13346_CR48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1474-4422(18)30029-2","volume":"17","author":"B Dubois","year":"2018","unstructured":"Dubois B, Epelbaum S, Nyasse F, Bakardjian H, Gagliardi G, Uspenskaya O, Houot M, Lista S, Cacciamani F, Potier MC, Bertrand A, Lamari F, Benali H, Mangin JF, Colliot O, Genthon R, Habert MO, Hampel H, Group IN-ps (2018) Cognitive and neuroimaging features and brain beta-amyloidosis in individuals at risk of Alzheimer\u2019s disease (INSIGHT-preAD): a longitudinal observational study. Lancet Neurol 17:335\u2013346","journal-title":"Lancet Neurol"},{"key":"13346_CR49","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/archneurol.2012.18107","volume":"69","author":"Y Huang","year":"2012","unstructured":"Huang Y, Potter R, Sigurdson W, Kasten T, Connors R, Morris JC, Benzinger T, Mintun M, Ashwood T, Ferm M, Budd SL, Bateman RJ (2012) \u03b2-Amyloid dynamics in human plasma. Arch Neurol 69:1591\u20131597","journal-title":"Arch Neurol"},{"key":"13346_CR50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13195-021-00889-2","volume":"13","author":"Tobias M\u00f6llers","year":"2021","unstructured":"M\u00f6llers T, Stocker H, Perna L, Nabers A, Rujescu D, Hartmann AM, Holleczek B, Sch\u00f6ttker B, Gerwert K, Brenner H (2021) A\u03b2 misfolding in blood plasma is inversely associated with body mass index even in middle adulthood. Alzheimers Res Ther 13:145","journal-title":"Alzheimers Res Ther"},{"key":"13346_CR51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12603-018-1121-6","volume":"23","author":"Mathieu Maltais","year":"2019","unstructured":"Maltais M, de Souto Barreto P, Rolland Y, Vellas B, MAPT\/DSA Study Group (2019) Is fat mass cross-sectionally associated with cortical A\u03b2 load in the human brain? J Nutr Health Aging 23:207\u2013210","journal-title":"J Nutr Health Aging"},{"key":"13346_CR52","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s12035-024-04320-3","volume":"62","author":"W Peng","year":"2024","unstructured":"Peng W, Yuan Y, Lei J, Zhao Y, Li Y, Qu QM, Wang J (2024) Long-term high-fat diet impairs AQP4-mediated glymphatic clearance of amyloid beta. Mol Neurobiol Null 62:1079\u20131093","journal-title":"Mol Neurobiol Null"},{"key":"13346_CR53","first-page":"e28","volume":"100","author":"Isabelle Glans","year":"2023","unstructured":"Glans I, Sonestedt E, N\u00e4gga K, Gustavsson AM, Gonz\u00e1lez-Padilla E, Borne Y, Stomrud E, Melander O, Nilsson PM, Palmqvist S, Hansson O (2023) Association between dietary habits in midlife with dementia incidence over a 20-year period. Neurology 100:e28\u2013e37","journal-title":"Neurology"},{"key":"13346_CR54","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1038\/s41380-022-01600-z","volume":"27","author":"Pai Liu","year":"2022","unstructured":"Liu P, Wang ZH, Kang SS, Liu X, Xia Y, Chan CB, Ye K (2022) High-fat diet-induced diabetes couples to Alzheimer\u2019s disease through inflammation-activated C\/EBP\u03b2\/AEP pathway. Mol Psychiatry 27:3396\u20133409","journal-title":"Mol Psychiatry"},{"key":"13346_CR55","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.4103\/1673-5374.373715","volume":"18","author":"Jingwen Jiang","year":"2023","unstructured":"Jiang J, Pan H, Shen F, Tan Y, Chen S (2023) Ketogenic diet alleviates cognitive dysfunction and neuroinflammation in APP\/PS1 mice via the Nrf2\/HO-1 and NF-\u03baB signaling pathways. Neural Regener Res 18:2767\u20132772","journal-title":"Neural Regener Res"},{"key":"13346_CR56","doi-asserted-by":"crossref","first-page":"1297984","DOI":"10.3389\/fnins.2023.1297984","volume":"17","author":"Matin Ramezani","year":"2023","unstructured":"Ramezani M, Fernando M, Eslick S, Asih PR, Shadfar S, Bandara EM, Hillebrandt H, Meghwar S, Shahriari M, Chatterjee P, Thota R, Dias CB, Garg ML, Martins RN (2023) Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer\u2019s disease. Front Neurosci 17:1297984","journal-title":"Front Neurosci"},{"key":"13346_CR57","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ana.26935","volume":"96","author":"Yevgenia Rosenblum","year":"2024","unstructured":"Rosenblum Y, Pereira M, Stange O, Weber FD, Bovy L, Tzioridou S, Lancini E, Neville DA, Klein N, de Wolff T, Stritzke M, Kersten I, Uhr M, Claassen JAHR, Steiger A, Verbeek MM, Dresler M (2024) Divergent associations of slow-wave sleep versus rapid eye movement sleep with plasma amyloid-beta. Ann Neurol 96:46\u201360","journal-title":"Ann Neurol"},{"key":"13346_CR58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrneurol.2013.269","volume":"10","author":"YE Ju","year":"2014","unstructured":"Ju YE, Lucey BP, Holtzman DM (2014) Sleep and Alzheimer disease pathology\u2014a bidirectional relationship. Nat Rev Neurol 10:115\u2013119","journal-title":"Nat Rev Neurol"},{"key":"13346_CR59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnagi.2019.00043","volume":"11","author":"S Ouanes","year":"2019","unstructured":"Ouanes S, Popp J (2019) High cortisol and the risk of dementia and Alzheimer\u2019s disease: a review of the literature. Front Aging Neurosci 11:43","journal-title":"Front Aging Neurosci"},{"key":"13346_CR60","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/jth.13209","volume":"14","author":"D Zamolodchikov","year":"2016","unstructured":"Zamolodchikov D, Renn\u00e9 T, Strickland S (2016) The Alzheimer\u2019s disease peptide \u03b2-amyloid promotes thrombin generation through activation of coagulation factor XII. J Thromb Haemostasis 14:995\u20131007","journal-title":"J Thromb Haemostasis"},{"key":"13346_CR61","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.3390\/ijms24087046","volume":"24","author":"A Badimon","year":"2023","unstructured":"Badimon A, Torrente D, Norris EH (2023) Vascular dysfunction in Alzheimer\u2019s disease: alterations in the plasma contact and fibrinolytic systems. Int J Mol Sci 24:7046","journal-title":"Int J Mol Sci"},{"key":"13346_CR62","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3389\/fimmu.2019.01534","volume":"10","author":"Yannick Chantran","year":"2019","unstructured":"Chantran Y, Capron J, Alamowitch S, Aucouturier P (2019) Anti-A\u03b2 antibodies and cerebral amyloid angiopathy complications. Front Immunol 10:1534","journal-title":"Front Immunol"},{"key":"13346_CR63","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1523\/JNEUROSCI.2797-06.2006","volume":"26","author":"KN Green","year":"2006","unstructured":"Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM (2006) Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer\u2019s disease. J Neurosci 26:9047\u20139056","journal-title":"J Neurosci"},{"key":"13346_CR64","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/alz.12756","volume":"18","author":"O Hansson","year":"2022","unstructured":"Hansson O, Edelmayer RM, Boxer AL, Carrillo MC, Mielke MM, Rabinovici GD, Salloway S, Sperling R, Zetterberg H, Teunissen CE (2022) The Alzheimer\u2019s Association appropriate use recommendations for blood biomarkers in Alzheimer\u2019s disease. Alzheimers Dement 18:2669\u20132686","journal-title":"Alzheimers Dement"},{"issue":"3","key":"13346_CR65","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/alz.12745","volume":"19","author":"L Beyer","year":"2023","unstructured":"Beyer L, Stocker H, Rujescu D, Holleczek B, Stockmann J, Nabers A, Brenner H, Gerwert K (2023) Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years. Alzheimers Dement 19(3):1020\u20131028","journal-title":"Alzheimers Dement"},{"key":"13346_CR66","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3233\/JAD-200777","volume":"78","author":"M Walter","year":"2020","unstructured":"Walter M, Wiltfang J, Vogelgsang J (2020) Pre-analytical sampling and storage conditions of amyloid-\u03b2 peptides in venous and capillary blood. J Alzheimers Dis 78:529\u2013535.","journal-title":"J Alzheimers Dis"},{"key":"13346_CR67","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jalz.2018.05.008","volume":"14","author":"O Hansson","year":"2018","unstructured":"Hansson O, Mikulskis A, Fagan AM, Teunissen C, Zetterberg H, Vanderstichele H, Molinuevo JL, Shaw LM, Vandijck M, Verbeek MM, Savage M, Mattsson N, Lewczuk P, Batrla R, Rutz S, Dean RA, Blennow K (2018) The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer\u2019s disease diagnosis: a review. Alzheimers Dement: J Alzheimers Assoc 14:1313\u20131333","journal-title":"Alzheimers Dement: J Alzheimers Assoc"},{"key":"13346_CR68","doi-asserted-by":"crossref","unstructured":"Chen Y, Zeng X, Diaz JL, Sehrawat A, Lafferty TK, Boslett JJ, Klunk WE, Pascoal TA, Villemagne VL, Cohen AD, Lopez OI, Yates NA, Karikari TK (2024) Effect of blood collection tube containing protease inhibitors on the pre-analytical stability of Alzheimer\u2019s disease plasma biomarkers. J Neurochem Null","DOI":"10.1101\/2024.03.05.24303504"},{"key":"13346_CR69","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/alz.12510","volume":"18","author":"IMW Verberk","year":"2022","unstructured":"Verberk IMW, Misdorp EO, Koelewijn J, Ball AJ, Blennow K, Dage JL, Fandos N, Hansson O, Hirtz C, Janelidze S, Kang S, Kirmess K, Kindermans J, Lee R, Meyer MR, Shan D, Shaw LM, Waligorska T, West T, Zetterberg H, Edelmayer RM, Teunissen CE (2022) Characterization of pre-analytical sample handling effects on a panel of Alzheimer\u2019s disease-related blood-based biomarkers: results from the Standardization of Alzheimer\u2019s Blood Biomarkers (SABB) working group. Alzheimers Dement 18:1484\u20131497","journal-title":"Alzheimers Dement"},{"key":"13346_CR70","doi-asserted-by":"crossref","first-page":"31","DOI":"10.11613\/BM.2014.006","volume":"24","author":"RAR Bowen","year":"2014","unstructured":"Bowen RAR, Remaley AT (2014) Interferences from blood collection tube components on clinical chemistry assays. Biochem Medica 24:31\u201344","journal-title":"Biochem Medica"},{"key":"13346_CR71","volume":"13","author":"Nicholas J Ashton","year":"2021","unstructured":"Ashton NJ, Su\u00e1rez-Calvet M, Karikari TK, Lantero-Rodriguez J, Snellman A, Sauer M, Simr\u00e9n J, Minguillon C, Fauria K, Blennow K, Zetterberg H (2021) Effects of pre-analytical procedures on blood biomarkers for Alzheimer\u2019s pathophysiology, glial activation, and neurodegeneration. Alzheimers Dement (Amsterdam, Netherlands) 13:e12168","journal-title":"Alzheimers Dement (Amsterdam, Netherlands)"},{"key":"13346_CR72","volume":"1","author":"Cara J Westmark","year":"2011","unstructured":"Westmark CJ, Hervey CM, Berry-Kravis EM, Malter JS (2011) Effect of anticoagulants on amyloid beta-protein precursor and amyloid beta levels in plasma. J Alzheimers Dis Parkinsonism 1:101","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"13346_CR73","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JAD-2009-0948","volume":"16","author":"OI Okereke","year":"2009","unstructured":"Okereke OI, Xia W, Irizarry MC, Sun X, Qiu WQ, Fagan AM, Mehta PD, Hyman BT, Selkoe DJ, Grodstein F (2009) Performance characteristics of plasma amyloid-beta 40 and 42 assays. J Alzheimers Dis 16:277\u2013285","journal-title":"J Alzheimers Dis"},{"key":"13346_CR74","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13195-021-00942-0","volume":"14","author":"AL Benedet","year":"2022","unstructured":"Benedet AL, Brum WS, Hansson O, Karikari TK, Zimmer ER, Zetterberg H, Blennow K, Ashton NJ (2022) The accuracy and robustness of plasma biomarker models for amyloid PET positivity. Alzheimers Res Ther 14:26","journal-title":"Alzheimers Res Ther"},{"key":"13346_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02709-z","author":"TR Hunter","year":"2024","unstructured":"Hunter TR, Santos LE, Tovar-Moll F, De Felice FG (2024) Alzheimer\u2019s disease biomarkers and their current use in clinical research and practice. Mol Psychiatry\u00a030:272\u2013284","journal-title":"Mol Psychiatry"},{"key":"13346_CR76","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.mcn.2005.12.003","volume":"31","author":"J Faur\u00e9","year":"2006","unstructured":"Faur\u00e9 J, Lachenal G, Court M, Hirrlinger J, Chatellard-Causse C, Blot B, Grange J, Schoehn G, Goldberg Y, Boyer V, Kirchhoff F, Raposo G, Garin J, Sadoul R (2006) Exosomes are released by cultured cortical neurones. Mol Cell Neurosci 31:642\u2013648","journal-title":"Mol Cell Neurosci"},{"key":"13346_CR77","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114486","volume":"190","author":"C Vandendriessche","year":"2022","unstructured":"Vandendriessche C, Kapogiannis D, Vandenbroucke RE (2022) Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer\u2019s disease. Adv Drug Deliv Rev 190:114486","journal-title":"Adv Drug Deliv Rev"},{"key":"13346_CR78","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1002\/alz.13055","volume":"19","author":"A Kumar","year":"2023","unstructured":"Kumar A, Su Y, Sharma M, Singh S, Kim S, Peavey JJ, Suerken CK, Lockhart SN, Whitlow CT, Craft S, Hughes TM, Deep G (2023) Microrna expression in extracellular vesicles as a novel blood-based biomarker for Alzheimer\u2019s disease. Alzheimers Dement 19:4952\u20134966","journal-title":"Alzheimers Dement"},{"key":"13346_CR79","first-page":"87","volume":"31","author":"TT Yang","year":"2018","unstructured":"Yang TT, Liu CG, Gao SC, Zhang Y, Wang PC (2018) The serum exosome derived MicroRNA-135a, -193b, and -384 were potential Alzheimer\u2019s disease biomarkers. Biomed Environ Sci 31:87\u201396","journal-title":"Biomed Environ Sci"},{"key":"13346_CR80","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.dadm.2019.02.002","volume":"11","author":"M R\u00f3zga","year":"2019","unstructured":"R\u00f3zga M, Bittner T, Batrla R, Karl J (2019) Preanalytical sample handling recommendations for Alzheimer\u2019s disease plasma biomarkers. Alzheimers Dement (N Y) 11:291\u2013300","journal-title":"Alzheimers Dement (N Y)"},{"key":"13346_CR81","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13195-019-0485-0","volume":"11","author":"O Hansson","year":"2019","unstructured":"Hansson O, Lehmann S, Otto M, Zetterberg H, Lewczuk P (2019) Advantages and disadvantages of the use of the CSF amyloid \u03b2 (A\u03b2) 42\/40 ratio in the diagnosis of Alzheimer\u2019s disease. Alzheimers Res Ther 11:34","journal-title":"Alzheimers Res Ther"},{"key":"13346_CR82","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13195-020-00728-w","volume":"12","author":"S De Meyer","year":"2020","unstructured":"De Meyer S, Schaeverbeke JM, Verberk IM, Gille B, De Schaepdryver M, Luckett ES, Gabel S, Bruffaerts R, Mauroo K, Thijssen EH, Stoops E, Vanderstichele HM, Teunissen CE, Vandenberghe R, Poesen K (2020) Comparison of ELISA-and SIMOA-based quantification of plasma A\u03b2 ratios for early detection of cerebral amyloidosis. Alzheimers Res Ther 12:162","journal-title":"Alzheimers Res Ther"},{"key":"13346_CR83","doi-asserted-by":"crossref","first-page":"e051969","DOI":"10.1002\/alz.051969","volume":"17","author":"R Yoda","year":"2021","unstructured":"Yoda R, Kaneko N, Korenaga A, Funatsu S, Sakashita N, Nishikaze T, Ohashi Y, Honda M, Hioki Y, Sekiya S, Ogata K, Iwamoto S, Tsujino K, Tanaka K (2021) Analytical validation of plasma amyloid \u03b2 measuring system by immunoprecipitation-mass spectrometry. Alzheimer\u2019s Dement 17:e051969","journal-title":"Alzheimer's Dement"},{"key":"13346_CR84","doi-asserted-by":"crossref","DOI":"10.4028\/b-7TThNX","volume":"10","author":"S Hu","year":"2024","unstructured":"Hu S, Zhang L, Su Y, Liang X, Yang J, Luo Q, Luo H (2024) Sensitive detection of multiple blood biomarkers via immunomagnetic exosomal PCR for the diagnosis of Alzheimer\u2019s disease. Sci Adv 10:eabm3088","journal-title":"Sci Adv"},{"key":"13346_CR85","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3233\/JAD-160325","volume":"54","author":"V P\u00e9rez-Grijalba","year":"2016","unstructured":"P\u00e9rez-Grijalba V, Fandos N, Canudas J, Insua D, Casabona D, Lacosta AM, Monta\u00f1\u00e9s M, Pesini P, Sarasa M (2016) Validation of Immunoassay-Based Tools for the Comprehensive Quantification of A\u03b240 and A\u03b242 Peptides in Plasma. J Alzheimers Dis 54:751\u201362","journal-title":"J Alzheimers Dis"},{"key":"13346_CR86","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13195-022-01104-6","volume":"14","author":"KY Kim","year":"2022","unstructured":"Kim KY, Park J, Jeong YH, Kim HJ, Lee E, Park JY, Kim E, Kim WJ (2022) Plasma amyloid-beta oligomer is related to subjective cognitive decline and brain amyloid status. Alzheimers Res Ther 14:162","journal-title":"Alzheimers Res Ther"},{"key":"13346_CR87","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.mex.2015.02.011","volume":"2","author":"L Janssen","year":"2015","unstructured":"Janssen L, Sobott F, De Deyn PP, Van Dam D (2015) Signal loss due to oligomerization in ELISA analysis of amyloid-beta can be recovered by a novel sample pre-treatment method. MethodsX 2:112\u201323","journal-title":"MethodsX"},{"key":"13346_CR88","doi-asserted-by":"crossref","unstructured":"Green PS, Kulstad JJ, Chea H, Craft S (2006) Proteomic analysis of amyloid beta binding proteins in human plasma. Alzheimer's & Dementia 3\u201398","DOI":"10.1016\/j.jalz.2006.05.1365"},{"key":"13346_CR89","doi-asserted-by":"crossref","unstructured":"Kuo YM, Kokjohn TA, Kalback W, Luehrs D, Galasko DR, Chevallier N, Koo EH, Emmerling MR, Roher AE (2000) Amyloid-\u03b2 Peptides Interact with Plasma Proteins and Erythrocytes: Implications for Their Quantitation in Plasma.Biochemical and Biophysical Research Communications 750\u2013756","DOI":"10.1006\/bbrc.2000.2222"},{"key":"13346_CR90","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1006\/bbrc.1999.0552","volume":"257","author":"YM Kuo","year":"1999","unstructured":"Kuo YM, Emmerling MR, Lampert HC, Hempelman SR, Kokjohn TA, Woods AS, Cotter RJ, Roher AE (1999) High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer\u2019s disease. Biochem Biophys Res Commun 257:787\u2013791","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"13346_CR91","doi-asserted-by":"publisher","first-page":"6168","DOI":"10.3390\/ijms23116168","volume":"23","author":"A Litus","year":"2022","unstructured":"Litus EA, Kazakov AS, Deryusheva EI, Nemashkalova EL, Shevelyova MP, Machulin AV, Nazipova AA, Permyakova ME, Uversky\nVN, Permyakov SE (2022) Ibuprofen favors binding of amyloid-\u03b2 peptide to its depot, serum albumin. Int J Mol Sci 23(11):6168. https:\/\/doi.org\/10.3390\/ijms23116168. PMID: 35682848; PMCID: PMC9181795","journal-title":"Int J Mol Sci"},{"key":"13346_CR92","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nm1635","volume":"13","author":"A Sagare","year":"2007","unstructured":"Sagare A, Deane R, Bell RD, Johnson B, Hamm K, Pendu R, Marky A, Lenting PJ, Wu Z, Zarcone T, Goate A, Mayo K, Perlmutter D, Coma M, Zhong Z, Zlokovic BV (2007) Clearance of amyloid-\u03b2 by circulating lipoprotein receptors. Nat Med 13:1029\u20131031","journal-title":"Nat Med"},{"key":"13346_CR93","first-page":"604141","volume":"2012","author":"P Pesini","year":"2012","unstructured":"Pesini P, P\u00e9rez-Grijalba V, Monle\u00f3n I, Boada M, T\u00e1rraga L, Mart\u00ednez-Lage P, San-Jos\u00e9 I, Sarasa M (2012) Reliable measurements of the \u03b2-amyloid pool in blood could help in the early diagnosis of AD. Int J Alzheimers Dis 2012:604141","journal-title":"Int J Alzheimers Dis"},{"key":"13346_CR94","doi-asserted-by":"crossref","unstructured":"Etsuro Matsubara, Blas Frangione, Jorge Ghiso (1995) Characterization of apolipoprotein J-Alzheimer\u2019s A\u03b2 interaction. J Biol Chem 7563-7567","DOI":"10.1074\/jbc.270.13.7563"},{"issue":"12","key":"13346_CR95","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jalz.2017.03.010","volume":"13","author":"WD Brubaker","year":"2017","unstructured":"Brubaker WD, Crane A, Johansson JU, Yen K, Garfinkel K, Mastroeni D, Asok P, Bradt B, Sabbagh M, Wallace TL, Glavis-Bloom C, Tenner AJ, Rogers J (2017) Peripheral complement interactions with amyloid \u03b2 peptide: Erythrocyte clearance mechanisms. Alzheimers Dement 13(12):1397\u20131409","journal-title":"Alzheimers Dement"},{"key":"13346_CR96","doi-asserted-by":"crossref","first-page":"164425","DOI":"10.1016\/j.scitotenv.2023.164425","volume":"892","author":"HY Magee","year":"2023","unstructured":"Magee HY, Maurer MM, Cobos A, Adhikari S, Halden RU (2023) Impact of LC\u2013MS\/MS quantification methods on analytical results by example of nationwide U.S. environmental samples. Sci Total Environ 892:164425","journal-title":"Sci Total Environ"},{"key":"13346_CR97","doi-asserted-by":"crossref","first-page":"13229","DOI":"10.1021\/acs.analchem.0c02381","volume":"92","author":"L Feng","year":"2020","unstructured":"Feng L, Huo Z, Xiong J, Li H (2020) Certification of amyloid-beta (A\u03b2) certified reference materials by amino acid-based isotope dilution high-performance liquid chromatography mass spectrometry and sulfur-based high-performance liquid chromatography isotope dilution inductively coupled plasma mass spectrometry. Anal Chem 92:13229\u201313237","journal-title":"Anal Chem"},{"key":"13346_CR98","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/10815589241246537","volume":"72","author":"Darren M Weber","year":"2024","unstructured":"Weber DM, Kim JC, Goldman SM, Clarke NJ, Racke MK (2024) New plasma LC\u2013MS\/MS assays for the quantitation of beta-amyloid peptides and identification of apolipoprotein E proteoforms for Alzheimer\u2019s disease risk assessment. J Investig Med: Off Publ Am Feder Clin Res 72:465\u2013474","journal-title":"J Investig Med: Off Publ Am Feder Clin Res"},{"key":"13346_CR99","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s12031-020-01510-1","volume":"70","author":"Shuai Zhang","year":"2020","unstructured":"Zhang S, Huang SY, An XB, Zeng L, Ai J (2020) Medical histories of control subjects influence the biomarker potential of plasma Abeta in Alzheimer\u2019s disease: a meta-analysis. J Mol Neurosci 70:861\u2013870","journal-title":"J Mol Neurosci"},{"key":"13346_CR100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-015-1477-1","volume":"130","author":"Y Xiang","year":"2015","unstructured":"Xiang Y, Bu XL, Liu YH, Zhu C, Shen LL, Jiao SS, Zhu XY, Giunta B, Tan J, Song WH, Zhou HD, Zhou XF, Wang YJ (2015) Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer\u2019s disease. Acta Neuropathol 130:487\u2013499","journal-title":"Acta Neuropathol"},{"key":"13346_CR101","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1007\/s12035-016-9826-1","volume":"54","author":"YR Wang","year":"2017","unstructured":"Wang YR, Wang QH, Zhang T, Liu YH, Yao XQ, Zeng F, Li J, Zhou FY, Wang L, Yan JC, Zhou HD, Wang YJ (2017) Associations between hepatic functions and plasma amyloid-beta levels-implications for the capacity of liver in peripheral amyloid-beta clearance. Mol Neurobiol 54:2338\u20132344","journal-title":"Mol Neurobiol"},{"key":"13346_CR102","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00002093-200207000-00009","volume":"16","author":"Z Arvanitakis","year":"2002","unstructured":"Arvanitakis Z, Lucas JA, Younkin LH, Younkin SG, Graff-Radford NR (2002) Serum creatinine levels correlate with plasma amyloid Beta protein. Alzheimer Dis Assoc Disord 16:187\u2013190","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"13346_CR103","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1038\/s41380-021-01073-6","volume":"26","author":"DingYuan Tian","year":"2021","unstructured":"Tian D-Y, Cheng Y, Zhuang Z-Q, He C-Y, Pan Q-G, Tang M-Z, Hu X-L, Shen Y-Y, Wang Y-R, Chen S-H, Sun H-L, Sun P-Y, Yu Z-Y, Fan D-Y, Bu X-L, Tan C-R, Zeng G-H, Wang J, Zhao H-W, Wang Y-J (2021) Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer\u2019s disease. Mol Psychiatry 26:6074\u20136082","journal-title":"Mol Psychiatry"},{"key":"13346_CR104","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12035-014-8854-y","volume":"52","author":"YuHui Liu","year":"2014","unstructured":"Liu Y-H, Xiang Y, Wang Y-R, Jiao S-S, Wang Q-H, Bu X-L, Zhu C, Yao X-Q, Giunta B, Tan J, Zhou H-D, Wang Y-J (2014) Association between serum amyloid-beta and renal functions: implications for roles of kidney in amyloid-beta clearance. Mol Neurobiol 52:115\u2013119","journal-title":"Mol Neurobiol"},{"key":"13346_CR105","first-page":"160","volume":"1","author":"L Broxmeyer","year":"2017","unstructured":"Broxmeyer L (2017) Dr. Oskar Fischer\u2019s curious little Alzheimer\u2019s germ. Sci Ricerca 1:160\u2013178","journal-title":"Sci Ricerca"},{"key":"13346_CR106","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S255309","author":"K Matsushita","year":"2020","unstructured":"Matsushita K, Yamada-Furukawa M, Kurosawa M, Shikama Y (2020) Periodontal disease and periodontal disease-related bacteria involved in the pathogenesis of Alzheimer\u2019s disease. J Inflamm Res. https:\/\/doi.org\/10.2147\/JIR.S255309","journal-title":"J Inflamm Res"},{"key":"13346_CR107","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3390\/jcm9020495","volume":"9","author":"M Dioguardi","year":"2020","unstructured":"Dioguardi M, Crincoli V, Laino L, Alovisi M, Sovereto D, Mastrangelo F, Lo Russo L, Lo Muzio L (2020) The role of periodontitis and periodontal bacteria in the onset and progression of Alzheimer\u2019s disease: a systematic review. J Clin Med 9:495","journal-title":"J Clin Med"},{"key":"13346_CR108","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.3390\/ijms23063091","volume":"23","author":"AF Uberti","year":"2022","unstructured":"Uberti AF, Callai-Silva N, Grahl MV, Piovesan AR, Nachtigall EG, Furini CR, Carlini CR (2022) Helicobacter pylori urease: potential contributions to Alzheimer\u2019s disease. Int J Mol Sci 23:3091","journal-title":"Int J Mol Sci"},{"key":"13346_CR109","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1038\/s41598-022-06749-9","volume":"12","author":"A Chacko","year":"2022","unstructured":"Chacko A, Delbaz A, Walkden H, Basu S, Armitage CW, Eindorf T, Trim LK, Miller E, West NP, St John JA (2022) Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer\u2019s disease risk. Sci Rep 12:2759","journal-title":"Sci Rep"},{"key":"13346_CR110","doi-asserted-by":"crossref","first-page":"e70013","DOI":"10.1111\/psyg.70013","volume":"25","author":"S Lehrer","year":"2024","unstructured":"Lehrer S, Rheinstein PH (2024) Klebsiella pneumoniae infection increases risk of Alzheimer Disease in the UK Biobank cohort. Psychogeriatrics 25:e70013","journal-title":"Psychogeriatrics"},{"key":"13346_CR111","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3233\/JAD-230170","volume":"94","author":"C Milano","year":"2023","unstructured":"Milano C, Hoxhaj D, Del Chicca M, Pascazio A, Paoli D, Tommasini L, Vergallo A, Pizzanelli C, Tognoni G, Nuti A (2023) Alzheimer\u2019s disease and neurosyphilis: meaningful commonalities and differences of clinical phenotype and pathophysiological biomarkers. J Alzheimers Dis 94:611\u2013625","journal-title":"J Alzheimers Dis"},{"key":"13346_CR112","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1128\/CMR.00118-13","volume":"27","author":"SJ Dando","year":"2014","unstructured":"Dando SJ, Mackay-Sim A, Norton R, Currie BJ, St. John JA, Ekberg JA, Batzloff M, Ulett GC, Beacham IR (2014) Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion. Clin Microbiol Rev 27:691\u2013726","journal-title":"Clin Microbiol Rev"},{"key":"13346_CR113","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13024-020-00378-4","volume":"15","author":"HR Bulgart","year":"2020","unstructured":"Bulgart HR, Neczypor EW, Wold LE, Mackos AR (2020) Microbial involvement in Alzheimer disease development and progression. Mol Neurodegener 15:42","journal-title":"Mol Neurodegener"},{"key":"13346_CR114","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fnagi.2018.00159","volume":"10","author":"R Alonso","year":"2018","unstructured":"Alonso R, Pisa D, Fern\u00e1ndez-Fern\u00e1ndez AM, Carrasco L (2018) Infection of fungi and bacteria in brain tissue from elderly persons and patients with Alzheimer\u2019s disease. Front Aging Neurosci 10:159","journal-title":"Front Aging Neurosci"},{"key":"13346_CR115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/nu15010051","volume":"15","author":"S Shi","year":"2022","unstructured":"Shi S, Zhang Q, Sang Y, Ge S, Wang Q, Wang R, He J (2022) Probiotic Bifidobacterium longum BB68S improves cognitive functions in healthy older adults: a randomized, double-blind, placebo-controlled trial. Nutrients 15:51","journal-title":"Nutrients"},{"key":"13346_CR116","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.jalz.2018.06.3040","volume":"14","author":"RD Moir","year":"2018","unstructured":"Moir RD, Lathe R, Tanzi RE (2018) The antimicrobial protection hypothesis of Alzheimer\u2019s disease. Alzheimers Dement 14:1602\u20131614","journal-title":"Alzheimers Dement"},{"key":"13346_CR117","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1007\/s12035-018-1388-y","volume":"56","author":"GM Ashraf","year":"2019","unstructured":"Ashraf GM, Tarasov VV, Makhmutova A, Chubarev VN, Avila-Rodriguez M, Bachurin SO, Aliev G (2019) The possibility of an infectious etiology of Alzheimer disease. Mol Neurobiol 56:4479\u20134491","journal-title":"Mol Neurobiol"},{"key":"13346_CR118","doi-asserted-by":"crossref","first-page":"12671","DOI":"10.3390\/ijms232012671","volume":"23","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Jaber VR, Pogue AI, Sharfman NM, Taylor C, Lukiw WJ (2022) Lipopolysaccharides (LPSs) as potent neurotoxic glycolipids in Alzheimer\u2019s disease (AD). Int J Mol Sci 23:12671","journal-title":"Int J Mol Sci"},{"key":"13346_CR119","doi-asserted-by":"crossref","first-page":"102068","DOI":"10.1016\/j.arr.2023.102068","volume":"91","author":"F Bruno","year":"2023","unstructured":"Bruno F, Abondio P, Bruno R, Ceraudo L, Paparazzo E, Citrigno L, Luiselli D, Bruni AC, Passarino G, Colao R, Maletta R, Montesanto A (2023) Alzheimer\u2019s disease as a viral disease: revisiting the infectious hypothesis. Ageing Res Rev 91:102068","journal-title":"Ageing Res Rev"},{"key":"13346_CR120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029480","volume":"6","author":"C F\u00e9art","year":"2011","unstructured":"F\u00e9art C, Helmer C, Fleury H, B\u00e9jot Y, Ritchie K, Amouyel P, Schraen-Maschke S, Bu\u00e9e L, Lambert J-C, Letenneur L, Dartigues J-F (2011) Association between IgM anti-herpes simplex virus and plasma amyloid-beta levels. PLoS ONE 6:e29480","journal-title":"PLoS ONE"},{"issue":"11","key":"13346_CR121","doi-asserted-by":"publisher","first-page":"e13989","DOI":"10.1371\/journal.pone.0013989","volume":"155","author":"JA Blaho","year":"2010","unstructured":"Blaho JA,De Chiara G, Marcocci ME, Civitelli L, Argnani R, Piacentini R, Ripoli C, Manservigi R, Grassi C, Garaci E, Palamara AT (2010) APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells. PLoS ONE155(11):e13989. https:\/\/doi.org\/10.1371\/journal.pone.0013989. PMID: 21085580; PMCID: PMC2981559","journal-title":"PLoS ONE"},{"issue":"2022","key":"13346_CR122","doi-asserted-by":"publisher","first-page":"8804925","DOI":"10.1155\/2022\/8804925","volume":"31","author":"T Ge","year":"2022","unstructured":"Ge T, Yuan Y (2022) Herpes simplex virus infection increases beta-amyloid production and induces the development of alzheimer's disease. Biomed Res Int 31(2022):8804925. https:\/\/doi.org\/10.1155\/2022\/8804925.","journal-title":"Biomed Res Int"},{"key":"13346_CR123","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/s41380-024-02428-5","volume":"29","author":"Meng Zhao","year":"2024","unstructured":"Zhao M, Ma G, Yan X, Li X, Wang E, Xu XX, Zhao JB, Ma X, Zeng J (2024) Microbial infection promotes amyloid pathology in a mouse model of Alzheimer\u2019s disease via modulating \u03b3-secretase. Mol Psychiatry 29:1491\u20131500","journal-title":"Mol Psychiatry"},{"key":"13346_CR124","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13365-015-0383-6","volume":"22","author":"MB Khan","year":"2016","unstructured":"Khan MB, Lang MJ, Huang MB, Raymond A, Bond VC, Shiramizu B, Powell MD (2016) Nef exosomes isolated from the plasma of individuals with HIV-associated dementia (HAD) can induce Abeta(1\u201342) secretion in SH-SY5Y neural cells. J Neurovirol 22:179\u2013190","journal-title":"J Neurovirol"},{"key":"13346_CR125","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.neurobiolaging.2013.04.015","volume":"34","author":"X Chen","year":"2013","unstructured":"Chen X, Hui L, Geiger NH, Haughey NJ, Geiger JD (2013) Endolysosome involvement in HIV-1 transactivator protein-induced neuronal amyloid beta production. Neurobiol Aging 34:2370\u20132378","journal-title":"Neurobiol Aging"},{"key":"13346_CR126","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11481-009-9152-8","volume":"4","author":"Cristian L Achim","year":"2009","unstructured":"Achim CL, Adame A, Dumaop W, Everall IP, Masliah E, HNRC (2009) Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol: Off J Soc NeuroImmune Pharmacol 4:190\u2013199","journal-title":"J Neuroimmune Pharmacol: Off J Soc NeuroImmune Pharmacol"},{"key":"13346_CR127","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1038\/s41380-022-01679-4","volume":"27","author":"Akihiko Urayama","year":"2022","unstructured":"Urayama A, Moreno-Gonzalez I, Morales-Scheihing D, Kharat V, Pritzkow S, Soto C (2022) Preventive and therapeutic reduction of amyloid deposition and behavioral impairments in a model of Alzheimer\u2019s disease by whole blood exchange. Mol Psychiatry 27:4285\u20134296","journal-title":"Mol Psychiatry"},{"key":"13346_CR128","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2147\/NDT.S241074","volume":"16","author":"Yuta Saito","year":"2020","unstructured":"Saito Y, Sakata M, Kobayakawa M, Kawachi H, Kawaguchi K, Hiki Y, Kato M, Mori M, Hasegawa M, Ohashi N, Yuzawa Y, Kitaguchi N (2020) Removal of A\u03b2 oligomers from the blood: a potential therapeutic system for Alzheimer\u2019s disease. Neuropsychiatr Dis Treat 16:607\u2013627","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"13346_CR129","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jalz.2014.10.008","volume":"11","author":"HM Snyder","year":"2014","unstructured":"Snyder HM, Corriveau RA, Craft S, Faber JE, Greenberg SM, Knopman D, Lamb BT, Montine TJ, Nedergaard M, Schaffer CB, Schneider JA, Wellington C, Wilcock DM, Zipfel GJ, Zlokovic B, Bain LJ, Bosetti F, Galis ZS, Koroshetz W, Carrillo MC (2014) Vascular contributions to cognitive impairment and dementia including Alzheimer\u2019s disease. Alzheimers Dement: J Alzheimers Assoc 11(6):710\u20137","journal-title":"Alzheimers Dement: J Alzheimers Assoc"},{"key":"13346_CR130","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1002\/alz.12930","volume":"19","author":"H Liu","year":"2023","unstructured":"Liu H, Barth\u00e9lemy NR, Ovod V, Bollinger JG, He Y, Chahin SL, Androff B, Bateman RJ, Lucey BP (2023) Acute sleep loss decreases CSF-to-blood clearance of Alzheimer\u2019s disease biomarkers. Alzheimers Dement 19:3055\u20133064","journal-title":"Alzheimers Dement"},{"key":"13346_CR131","doi-asserted-by":"crossref","first-page":"313","DOI":"10.31635\/ccschem.019.20180034","volume":"1","author":"H Qin","year":"2019","unstructured":"Qin H, Wang J, Ren J, Qu X (2019) Amyloid \u03b2 and tumorigenesis: amyloid \u03b2-induced telomere dysfunction in tumor cells. CCS Chem 1:313\u2013325","journal-title":"CCS Chem"},{"key":"13346_CR132","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1158\/2159-8290.CD-21-1006","volume":"12","author":"K Kleffman","year":"2022","unstructured":"Kleffman K, Levinson G, Rose IVL, Blumenberg LM, Shadaloey SAA, Dhabaria A, Wong E, Galan-Echevarria F, Karz A, Argibay D, Von Itter R, Floristan A, Baptiste G, Eskow NM, Tranos JA, Chen J, Vega y Saenz de Miera EC, Call M, Rogers R, Jour G, Wadghiri YZ, Osman I, Li YM, Mathews P, DeMattos RB, Ueberheide B, Ruggles KV, Liddelow SA, Schneider RJ, Hernando E (2022) Melanoma-secreted amyloid beta suppresses neuroinflammation and promotes brain metastasis. Cancer Discov 12:1314\u20131335","journal-title":"Cancer Discov"},{"key":"13346_CR133","doi-asserted-by":"crossref","unstructured":"Kihwan H, Myounggyu N, Jay JP, Kwang-Sung A, Junhyung K, So Young J, Jung Ho H, Chae Yong K (2021) Serum amyloid beta-42 as a noninvasive biomarker for the prognosis and histologic features of glioma. Res Sq (Res Sq)","DOI":"10.21203\/rs.3.rs-836779\/v1"},{"key":"13346_CR134","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/glia.22350","volume":"61","author":"C Cunningham","year":"2013","unstructured":"Cunningham C (2013) Microglia and neurodegeneration: the role of systemic inflammation. Glia 61:71\u201390","journal-title":"Glia"},{"key":"13346_CR135","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16:358\u2013372","journal-title":"Nat Rev Neurosci"},{"key":"13346_CR136","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1084\/jem.20162011","volume":"214","author":"E Czirr","year":"2017","unstructured":"Czirr E, Castello NA, Mosher KI, Castellano JM, Hinkson IV, Lucin KM, Baeza-Raja B, Ryu JK, Li L, Farina SN, Belichenko NP, Longo FM, Akassoglou K, Britschgi M, Cirrito JR, Wyss-Coray T (2017) Microglial complement receptor 3 regulates brain A\u03b2 levels through secreted proteolytic activity. J Exp Med 214:1081\u20131092","journal-title":"J Exp Med"},{"key":"13346_CR137","doi-asserted-by":"crossref","first-page":"10235","DOI":"10.3390\/ijms231810235","volume":"23","author":"R Versele","year":"2022","unstructured":"Versele R, Sevin E, Gosselet F, Fenart L, Candela P (2022) TNF-\u03b1 and IL-1\u03b2 modulate blood-brain barrier permeability and decrease amyloid-\u03b2 peptide efflux in a human blood-brain barrier model. Int J Mol Sci 23:10235","journal-title":"Int J Mol Sci"},{"key":"13346_CR138","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41419-020-2644-4","volume":"11","author":"Z He","year":"2020","unstructured":"He Z, Yang Y, Xing Z, Zuo Z, Wang R, Gu H, Qi F, Yao Z (2020) Intraperitoneal injection of IFN-\u03b3 restores microglial autophagy, promotes amyloid-\u03b2 clearance and improves cognition in APP\/PS1 mice. Cell Death Dis 11:440","journal-title":"Cell Death Dis"},{"key":"13346_CR139","doi-asserted-by":"crossref","unstructured":"Saavedra-L\u00f3pez E, Casanova P, Cribaro G, Barcia C (2016) Neuroinflammation in movement disorders. In: Handbook of behavioral neuroscience. Elsevier, Amsterdam 24:771\u2013782","DOI":"10.1016\/B978-0-12-802206-1.00038-6"},{"key":"13346_CR140","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/jnnp.74.9.1200","volume":"74","author":"E Tarkowski","year":"2003","unstructured":"Tarkowski E, Andreasen N, Tarkowski A, Blennow K (2003) Intrathecal inflammation precedes development of Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 74:1200\u20131205","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13346_CR141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-9-151","volume":"9","author":"D Krstic","year":"2012","unstructured":"Krstic D, Madhusudan A, Doehner J, Vogel P, Notter T, Imhof C, Manalastas A, Hilfiker M, Pfister S, Schwerdel C (2012) Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice. J Neuroinflammation 9:1\u201324","journal-title":"J Neuroinflammation"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13346-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13346-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13346-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:57:45Z","timestamp":1773665865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13346-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":141,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["13346"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13346-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have nothing to disclose. This systematic review did not receive any corporate funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"30"}}